We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Miniaturized Device Monitors Blood Metabolites in ICU

By LabMedica International staff writers
Posted on 03 Nov 2015
A miniaturized microfluidic device could allow healthcare workers to monitor key metabolites in real time in intensive care units (ICUs).

Developed by researchers at Ecole Polytechnique Fédérale de Lausanne (EPFL; Switzerland) the device consists of a little black box with embedded biosensors that is attached to a patient’s drainage tube. More...
The prototype device, fabricated using a three dimensional (3-D) printer, can currently monitor real time levels of glucose, lactate, bilirubin, calcium, and potassium. Eventually, according to the researchers, up to 40 different molecules could be monitored using the device, thus reducing the need for additional diagnostic devices.

The prototype includes a fully integrated hardware platform on a printed circuit board (PCB) that connects the biosensors to a read-out on the front end, as well as wireless connectivity via a Bluetooth module for data transmission to a mobile Android interface for visualization. Preliminary in vitro tests on calibration for the five key metabolites of interest were conducted successfully on rodents. A study describing the device and the results was presented at the annual Biomedical Circuits and Systems Conference (BioCAS), held during October 2015 in Atlanta (GA, USA).

“We embedded biosensors in it to measure several different substances in the blood or blood serum along with an array of electronics to transmit the results in real time to a tablet via Bluetooth,” said study presenter Sandro Carrara, PhD, a scientist at the EPFL integrated systems laboratory (LSI). “Nowadays, several of these levels are measured periodically. But in some cases, any change in level calls for an immediate response, something that is not possible with the existing systems.”

Microfluidics intersects engineering, physics, chemistry, biochemistry, nanotechnology, and biotechnology, in order to process low volumes of fluid for multiplexing, automation, and high-throughput screening. Behavior, control, and manipulation of the fluids is geometrically constrained to a small, typically submillimeter, scale using passive fluid control techniques, such as capillary forces. Often processes which are normally carried out in a lab are miniaturized on a single chip in order to enhance efficiency and mobility, as well as reducing sample and reagent volumes.

Related Links:

Ecole Polytechnique Fédérale de Lausanne



Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Nutating Mixer
Enduro MiniMix
New
HbA1c Test
HbA1c Rapid Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: Schematic diagram of multimodal single-cell MSI using tapping-mode scanning probe electrospray ionization (Photo courtesy of Yoichi Otsuka)

New Technology Improves Understanding of Complex Biological Samples

Tissues are composed of a complex mixture of various cell types, which complicates our understanding of their biological roles and the study of diseases. Now, a multi-institutional team of researchers... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.